Exact Mass: 357.1760112

Exact Mass Matches: 357.1760112

Found 60 metabolites which its exact mass value is equals to given mass value 357.1760112, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Uplandicine

Uplandicine; 7-Acetyl-9-echimidinylretronecine

C17H27NO7 (357.1787432)


   

Cinacalcet

alpha-Methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphar)-hydrochloride

C22H22F3N (357.17042480000003)


Cinacalcet (INN) is a drug that acts as a calcimimetic (i.e. it mimics the action of calcium on tissues) by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. It is sold by Amgen under the trade name Sensipar in North America and Australia and as Mimpara in Europe. Cinacalcet is used to treat hyperparathyroidism (elevated parathyroid hormone levels), a consequence of parathyroid tumors and chronic renal failure. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

   

(3R,5R)-3-Butyl-3-ethyl-5-phenyl-4,5-dihydro-2H-1$l^{6},4-benzothiazepine 1,1-dioxide

(3R,5R)-3-Butyl-3-ethyl-5-phenyl-4,5-dihydro-2H-1$l^{6},4-benzothiazepine 1,1-dioxide

C21H27NO2S (357.17624020000005)


   

Quinocarmycin analog

12-cyano-10-(hydroxymethyl)-8-methoxy-16-methyl-11,16-diazatetracyclo[11.2.1.0^{2,11}.0^{4,9}]hexadeca-4(9),5,7-triene-15-carboxylic acid

C19H23N3O4 (357.16884780000004)


D000970 - Antineoplastic Agents

   
   

JWH 018 4-hydroxyindole metabolite

(4-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   
   

JWH 018 5-hydroxyindole metabolite

(5-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   

(6-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone

(6-hydroxy-1-pentylindol-3-yl)-naphthalen-1-ylmethanone

C24H23NO2 (357.1728698)


   

JWH 018 7-hydroxyindole metabolite

(7-hydroxy-1-pentyl-1H-indol-3-yl)naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   
   
   

JWH 018 8-quinolinyl carboxamide

JWH 018 8-quinolinyl carboxamide

C23H23N3O (357.1841028)


   
   

N-(naphthalen-1-yl)-2-pentyl-2h-indazole-3-carboxamide

N-(naphthalen-1-yl)-2-pentyl-2h-indazole-3-carboxamide

C23H23N3O (357.1841028)


   

(1-butylindol-3-yl)-(4-methoxynaphthalen-1-yl)methanone

(1-butylindol-3-yl)-(4-methoxynaphthalen-1-yl)methanone

C24H23NO2 (357.1728698)


   
   
   
   
   
   
   

3-Acetylindicine N-oxide

3-Acetylindicine N-oxide

C17H27NO7 (357.1787432)


   

C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)

NCGC00380403-01_C19H23N3O4_2H-Pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione, 6-acetyl-6,10b,11,11a-tetrahydro-10b-hydroxy-3-(2-methylpropyl)-

C19H23N3O4 (357.16884780000004)


   

JWH 018 2-hydroxyindole metabolite

(2-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   

JWH 018 6-hydroxyindole metabolite

(6-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   

JWH 018 N-(5-hydroxypentyl) metabolite

(1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C24H23NO2 (357.1728698)


   

Cinacalcet

[(1R)-1-(naphthalen-1-yl)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine

C22H22F3N (357.17042480000003)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D057966 - Calcimimetic Agents H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor D000077264 - Calcium-Regulating Hormones and Agents

   

(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite

(S)-(+)-JWH 018 N-(4-hydroxypentyl) metabolite

C24H23NO2 (357.1728698)


   

(±)-JWH 018 N-(3-hydroxypentyl) metabolite

(±)-JWH 018 N-(3-hydroxypentyl) metabolite

C24H23NO2 (357.1728698)


   

(±)-JWH 018 N-(2-hydroxypentyl) metabolite

(±)-JWH 018 N-(2-hydroxypentyl) metabolite

C24H23NO2 (357.1728698)


   

6-Acetyl-10b-hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

6-Acetyl-10b-hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C19H23N3O4 (357.16884780000004)


   

4-ISOTHIOCYANATOPHENYL 4-PENTYLBICYCLO

4-ISOTHIOCYANATOPHENYL 4-PENTYLBICYCLO

C21H27NO2S (357.17624020000005)


   

(S)-(+)-3-METHYL-2-BUTYLAMINE

(S)-(+)-3-METHYL-2-BUTYLAMINE

C24H23NO2 (357.1728698)


   

2-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide

2-((tert-butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide

C20H27NO3Si (357.1760112)


   

Cafedrine

(-)-Cafedrine

C18H23N5O3 (357.18008080000004)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Setastine

1-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]azepane

C22H28ClNO (357.18593080000005)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

4,7-dimethyl-5,6-bis(phenylmethoxy)-1H-indole

4,7-dimethyl-5,6-bis(phenylmethoxy)-1H-indole

C24H23NO2 (357.1728698)


   

(R)-(-)-5-(TRITYLOXYMETHYL)-2-PYRROLIDONE

(R)-(-)-5-(TRITYLOXYMETHYL)-2-PYRROLIDONE

C24H23NO2 (357.1728698)


   

4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)phenyl]morpholine

4-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)phenyl]morpholine

C17H23BF3NO3 (357.17229940000004)


   

2-({6-[(3R)-3-Amino-1-piperidinyl]-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl}methyl)benzamide

2-({6-[(3R)-3-Amino-1-piperidinyl]-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl}methyl)benzamide

C18H23N5O3 (357.18008080000004)


   
   

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine

(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine

C22H22F3N (357.17042480000003)


   
   

N-Biotinyl-6-aminohexanoic acid

6-[5-(2-Oxo-hexahydro-thieno[3,4-D]imidazol-4-YL)-pentanoylamino]-hexanoic acid

C16H27N3O4S (357.17221820000003)


   

Olorinab

Olorinab

C18H23N5O3 (357.18008080000004)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

4-(2-Pyridyl)piperazinyl 3,4,5-trimethoxyphenyl ketone

4-(2-Pyridyl)piperazinyl 3,4,5-trimethoxyphenyl ketone

C19H23N3O4 (357.16884780000004)


   

Protubonine A

Protubonine A

C19H23N3O4 (357.16884780000004)


An organic heterotetracyclic compound that is 6,10b,11,11a-tetrahydro-H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-,4(3H,5aH)-dione substituted by an acetyl group at position 6, a hydroxy group at position 10b and a 2-methylpropyl group at position 3. It has been isolated from in Aspergillus species. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

   

N-[6-(2-amino-4-fluoroanilino)-6-oxohexyl]-4-methylbenzamide

N-[6-(2-amino-4-fluoroanilino)-6-oxohexyl]-4-methylbenzamide

C20H24FN3O2 (357.1852456)


   

2-(Phenylmethyl)-5-[4-(phenylmethyl)-1-piperidinyl]-4-oxazolecarbonitrile

2-(Phenylmethyl)-5-[4-(phenylmethyl)-1-piperidinyl]-4-oxazolecarbonitrile

C23H23N3O (357.1841028)


   

N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

C19H23N3O4 (357.16884780000004)


   

4-[[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]-1,3-oxazole

4-[[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]-1,3-oxazole

C23H23N3O (357.1841028)


   

16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O4 (357.16884780000004)


   

(1r,4s,7r,9r)-16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7r,9r)-16-acetyl-6,9-dihydroxy-4-(2-methylpropyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O4 (357.16884780000004)


   

(2e)-3-[(8r)-8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

(2e)-3-[(8r)-8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

C19H23N3O4 (357.16884780000004)


   

3-{8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

3-{8,11-dimethoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

C19H23N3O4 (357.16884780000004)


   

(1r,3r,5s,6r)-8-methyl-6-(1h-pyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

(1r,3r,5s,6r)-8-methyl-6-(1h-pyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate

C19H23N3O4 (357.16884780000004)